Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidsel Pedersen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2026
Impact of adjuvant anti-PD-1 immunotherapy on ovarian function in female patients with resectable melanoma: A prospective observational studySidsel Pedersen, Lotte B Colmorn, Eva Ellebaek, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2024
Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanomaRikke B Holmstroem, Sidsel Pedersen, Rebecca Jurlander, et al.
Nature Communications|December 14, 2025
Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanomaSidsel Pedersen, Mikkel Byrdal, Evelina Martinenaite, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2023
Sustained improved survival of patients with metastatic melanoma after the introduction of anti-PD-1-based therapiesAimilia Schina, Sidsel Pedersen, Anne-Louise Spenning, et al.
Acta Oncologica (Stockholm, Sweden)|January 16, 2023
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapySidsel Pedersen, Rikke B Holmstroem, Annika von Heymann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2025
Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022)Sidsel Pedersen, Emma Lund Johansen, Karen Louise Højholt, et al.
Journal for Immunotherapy of Cancer|June 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanomaJames William Smithy, Allison Betof, Sebastian Klobuch, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2026
Impact of adjuvant anti-PD-1 immunotherapy on ovarian function in female patients with resectable melanoma: A prospective observational studySidsel Pedersen, Lotte B Colmorn, Eva Ellebaek, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2024
Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanomaRikke B Holmstroem, Sidsel Pedersen, Rebecca Jurlander, et al.
Nature Communications|December 14, 2025
Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanomaSidsel Pedersen, Mikkel Byrdal, Evelina Martinenaite, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2023
Sustained improved survival of patients with metastatic melanoma after the introduction of anti-PD-1-based therapiesAimilia Schina, Sidsel Pedersen, Anne-Louise Spenning, et al.
Acta Oncologica (Stockholm, Sweden)|January 16, 2023
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapySidsel Pedersen, Rikke B Holmstroem, Annika von Heymann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2025
Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022)Sidsel Pedersen, Emma Lund Johansen, Karen Louise Højholt, et al.
Journal for Immunotherapy of Cancer|June 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanomaJames William Smithy, Allison Betof, Sebastian Klobuch, et al.
Pageof 2